# 68Ga-FAPI PET/CT in Liver Fibrosis Patients

> **NCT04533828** · EARLY_PHASE1 · UNKNOWN · sponsor: **First Affiliated Hospital of Fujian Medical University** · enrollment: 50 (estimated)

## Conditions studied

- Liver Fibrosis
- Positron Emission Tomography

## Interventions

- **DRUG:** 68Ga-FAPI-04

## Key facts

- **NCT ID:** NCT04533828
- **Lead sponsor:** First Affiliated Hospital of Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-12-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04533828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04533828, "68Ga-FAPI PET/CT in Liver Fibrosis Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04533828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*